150 related articles for article (PubMed ID: 38589444)
21. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
22. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
[TBL] [Abstract][Full Text] [Related]
23. Study on the relationship between CXCR3 and its ligands and tubal tuberculosis.
Sun H; Fan J; Shang X; Tuohetaerbaike B; Li Y; Lv J; Wang Y; Wang L; Wang J; Ma X
Life Sci; 2021 May; 272():119047. PubMed ID: 33454369
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Hueso L; Ortega R; Selles F; Wu-Xiong NY; Ortega J; Civera M; Ascaso JF; Sanz MJ; Real JT; Piqueras L
Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
[TBL] [Abstract][Full Text] [Related]
25. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.
Burns WR; Wang Y; Tang PC; Ranjbaran H; Iakimov A; Kim J; Cuffy M; Bai Y; Pober JS; Tellides G
Am J Transplant; 2005 Jun; 5(6):1226-36. PubMed ID: 15888026
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
[TBL] [Abstract][Full Text] [Related]
27. Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis.
Hakimi M; Peters A; Becker A; Böckler D; Dihlmann S
J Vasc Surg; 2014 Mar; 59(3):794-803. PubMed ID: 23790454
[TBL] [Abstract][Full Text] [Related]
28. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
29. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.
Loiseau C; Requena M; Nayrac M; Mavigner M; Cazabat M; Iscache AL; Carrere N; Suc B; Alric L; Izopet J; Delobel P
J Infect Dis; 2019 Jul; 220(5):830-840. PubMed ID: 30880342
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
Marx N; Mach F; Sauty A; Leung JH; Sarafi MN; Ransohoff RM; Libby P; Plutzky J; Luster AD
J Immunol; 2000 Jun; 164(12):6503-8. PubMed ID: 10843708
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation by IFN‑γ on TNF‑α‑induced chemokine expression in synovial fibroblasts from temporomandibular joint.
Ohta K; Naruse T; Kato H; Ishida Y; Nakagawa T; Ono S; Shigeishi H; Takechi M
Mol Med Rep; 2017 Nov; 16(5):6850-6857. PubMed ID: 28901435
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
33. Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line.
Matsumoto A; Hiroi M; Mori K; Yamamoto N; Ohmori Y
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218983
[TBL] [Abstract][Full Text] [Related]
34. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
[TBL] [Abstract][Full Text] [Related]
35. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.
Mach F; Sauty A; Iarossi AS; Sukhova GK; Neote K; Libby P; Luster AD
J Clin Invest; 1999 Oct; 104(8):1041-50. PubMed ID: 10525042
[TBL] [Abstract][Full Text] [Related]
37. FGF signaling contributes to atherosclerosis by enhancing the inflammatory response in vascular smooth muscle cells.
Qi M; Xin S
Mol Med Rep; 2019 Jul; 20(1):162-170. PubMed ID: 31115530
[TBL] [Abstract][Full Text] [Related]
38. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
39. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells.
Sheikh AM; Ochi H; Manabe A; Masuda J
Cardiovasc Res; 2005 Jan; 65(1):263-71. PubMed ID: 15621055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
